Drug
Ginger Extract
Ginger Extract is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Phase Distribution
Ph phase_2
3
50%
Ph not_applicable
2
33%
Ph early_phase_1
1
17%
Phase Distribution
1
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 2Efficacy & side effects
3(50.0%)
N/ANon-phased studies
2(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(5)
Detailed Status
Completed5
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (16.7%)
Phase 23 (50.0%)
N/A2 (33.3%)
Trials by Status
completed583%
not_yet_recruiting117%
Recent Activity
0 active trials
Showing 5 of 6
not_yet_recruitingphase_2
Ginger's Therapeutic Potential in Asthma
NCT07792395
completednot_applicable
Anti-Ageing Health Supplement From Ginger Extracts
NCT06828783
completedearly_phase_1
Ginger's Therapeutic Potential in Asthma
NCT03705832
completednot_applicable
Ginger and Gut Microbiome (GINGER)
NCT03268655
completedphase_2
Study of Efficacy and Safety of Ginger Extract Compared With Loratadine for Treatment of Allergic Rhinitis
NCT02576808
Clinical Trials (6)
Showing 6 of 6 trials
NCT07792395Phase 2
Ginger's Therapeutic Potential in Asthma
NCT06828783Not Applicable
Anti-Ageing Health Supplement From Ginger Extracts
NCT03705832Early Phase 1
Ginger's Therapeutic Potential in Asthma
NCT03268655Not Applicable
Ginger and Gut Microbiome (GINGER)
NCT02576808Phase 2
Study of Efficacy and Safety of Ginger Extract Compared With Loratadine for Treatment of Allergic Rhinitis
NCT00064272Phase 2
UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6